Medicines and Other Health Products

FIP Call to Action: Mobilising pharmacists across our communities to mitigate the impact of air pollution on health The Global Threat of Air Pollution and Its Impact on Patient Care: Supporting Pharmacy Practice and Workforce Development FIP Statement of Principle: Accelerating vaccine equity for pharmacy teams on the front line Pharmacy based pandemic vaccination programme: regulatory self-assessment tool FIP Holding Statement on in-pharmacy COVID-19 testing Intervention on provisional agenda item 14.1 COVID-19 response (WHO148th executive board) Community pharmacists have a crucial role to play in responsible over-the-counter pain management Intervention on provisional agenda item 14.1 COVID-19 response (WHO 148th executive board) Joint statement on substandard and falsified medical products (74th WHA) Joint statement on public health emergencies and mental health preparedness for and response to the COVID-19 pandemic FIP vaccination handbook for pharmacists: Procedures, safety aspects, common risk points and frequent questions Off-label drug use written into Chinese medical law for the first time Community pharmacy is critical to recovery following the COVID-19 pandemic Medicines reconciliation: A toolkit for pharmacists Community Pharmacy Global Report 2021 (Available for FIP members only) Community pharmacy at a glance 2021 Mitigating the impact of air pollution on health: The role of community pharmacists The FIP Development Goals COVID-19: Evaluation of diagnostic testing methods and devices Addendum to FIP COVID-19 Guidance (November 2020) Holding Statement on interferon beta and vaccination for COVID-19 FIP COVID-19 guidance (Part 2): Guidelines for pharmacists and the pharmacy workforce FIP COVID-19 guidance (Part 1): Clinical information and treatment guidelines FIP COVID-19 Summary 2: Pharmacy operations and facilities FIP COVID-19 Summary 3: Community pharmacy procedures FIP COVID-19 Summary 4: Community pharmacy contingency plans FIP COVID-19 Summary 6: Cleaning and disinfection management FIP COVID-19 Summary 7: Treatment guidelines and medicines to be stoked FIP COVID-19 Summary 8: Use of masks FIP COVID-19 Summary 9: Notice to community pharmacy and customers FIP holding statement on the use of masks during COVID-19 FIP holding statement on COVID-19 treatment with hydroxychloroquine/chloroquine (June 2020) FIP statement of principle: Impact of the COVID-19 pandemic on health equity, and vulnerable patients and populations Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues. Universal health coverage: moving together to build a healthier world FIP Statement of Policy on Medicines Shortages Intervention on provisional agenda item global vaccine action plan Intervention on provisional agenda item 6. Primary health care Position statement on the use of ibuprofen and other medicines in COVID-19 pandemic Primary health care (73rd WHA) Acceso sostenible y equitativo a las vacunas: Establecimiento de prioridades y fijación de políticas en la región de las Américas FIP Regional Conference for the European Region Delivering primary health care: Pharmacists taking the next leap forward Patient safety: Pharmacists' role in "Medication without harm" Give it a shot: Expanding immunisation coverage through pharmacists Ankara Commitment to Action on Primary Health Care Amman Commitment to Action on Primary Health Care Joint Statement of Policy by FIP and the Global Self-Care Federation on Responsible and Effective Self-Care The role of pharmacists in non-communicable diseases FIP's intervention on universal coverage (72nd WHA) FIP's intervention on tobacco (72nd WHA) FIP Strategic Plan: 2019 - 2024 Pharmacists in the supply chain: The role of the medicines expert in ensuring quality and availability Pharmacists' authority in pharmaceutical product selection: Therapeutic interchange and substitution Addressing the global shortages of, and access to medicines and vaccines (142nd WHO Executive Board) Addressing the global shortage of, and access to medicines and vaccines Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits Use of medicines by the elderly: The role of pharmacy in promoting adherence Is there a "Holy Grail" medicine? The Good Pharmacy Practice guidelines "Budesonide-formoterol as reliever inhaler: A pilot programme featuring Canadian community pharmacist implementation of recent asthma guideline updates " Social prescribing by community pharmacists: A missed opportunity for health systems globally ARV supply and demand — 10 years of successes and challenges at the Antiretroviral Procurement Working Group

Supporting self-care: Women's health Understanding vaccine hesitancy and building vaccine confidence through effective conversations Leveraging pharmacists to minimise the impact of air pollution on health: Policy barriers and drivers Understanding and managing 21st century headaches in the community Dynamics shaping the future self-care market FIP “Setting goals for the decade ahead” | Episode 11 | FIP DG 7: Advancing integrated services Understanding and managing headaches in the community: Therapeutic approaches and advancements in the African region Understanding and managing headaches in the community: Therapeutic approaches and advancements in the Western Pacific region FIP “Setting goals for the decade ahead” | Episode 12 | FIP DG 2: Early career training strategy Trusted for health- Pharmacy, Medication Adherence & Communication Trusted for health: Pharmacy and Counterfeit Medicines worldwide- problems and solutions Optimising opioid use through pharmacists Health illiteracy and vaccine misinformation as determinants for equity: developing policies to establish access to quality information in an equitable way The pharmacist in the prevention and management of vector-borne diseases: a perspective from the Southeast Asian region Community pharmacy roles, services and tools to minimise impact of air pollution on health Selfcare in the digital age Vaccinations and the genders: Examining inequities in gender access and handling of vaccinations globally to inform pharmacy policy FIP “Setting goals for the decade ahead” | Episode 10 | FIP DG 4: Advanced and specialist development Pharmacists’ experiences in crises in Lebanon: The Lebanese financial crisis, COVID-19 pandemic, and the Beirut Port blast. Supporting self-care: Footcare in diabetes management Developing Effective Pharmacy-led Vaccination Campaigns Readying the global population for self-care: Health literacy in the 2020s The role of pharmacists in the prevention and management of vector-borne diseases: a perspective from the Western Pacific region FIP “Setting goals for the decade ahead” | Episode 9 | FIP DG 6: Leadership development Looking ahead: Post-pandemic recovery and restoration of services Equity, access & sustainability through life’s ages and stages: Enabling a life course-approach to vaccination FIP “Setting goals for the decade ahead” | Episode 8 | FIP DG 15: People-centred care Pharmacists in long-term care facilities: Before, during and after the pandemic Supporting self-care: musculoskeletal pain and chronicity Joining forces across health professionals towards improved vaccination coverage Medication adherence workshop FIP “Setting goals for the decade ahead” | Episode 7 | FIP DG 9: Continuing professional development strategies The role of pharmacists in the prevention and management of vector-borne diseases: a perspective from the Eastern Mediterranean region Introducing the FIP ‘Transforming Vaccination Globally, Regional and Nationally’ 2021: Accelerating equity, access and sustainability through policy development and implementation Delivering person-centred support for self-care: current and future pharmacy practice Outdoor and indoor air pollution: short- and long-term impacts on health FIP “Setting goals for the decade ahead” | Episode 6 | FIP DG 21: Sustainability in pharmacy Obesity and weight management: Pharmacist-led services and approaches Drugs to tackle a pandemic – something old and something new Appropriate management in the choice of medicines for self-care Nutritional approaches to the prevention and management of non-communicable diseases: Roles for pharmacists FIP “Setting goals for the decade ahead” | Episode 5 | FIP DG 1: Academic capacity The role of the pharmacist in the prevention and management of vector-borne diseases: African region Shaping the future of self-care: healthcare needs & challenges FIP “Setting goals for the decade ahead” | Episode 4 | FIP DG 20: Digital health FIP “Setting goals for the decade ahead” | Episode 3 | FIP DG 16: Communicable diseases El farmacéutico en la prevención y manejo de las enfermedades transmisibles por vectores: una perspectiva de la región de las Américas Medicines reconciliation: an essential pharmacist-led service to ensuring patient safety Reducing medication harm through medicines use reviews: pharmacists at the frontline FIP “Setting goals for the decade ahead” | Episode 2 | FIP DG 18: Access to medicines, devices & services FIP “Setting goals for the decade ahead” | Episode 1 | FIP DG 10: Equity & equality Generic Drug Global Landscape - An FDA Perspective FIP Global Virtual Summit: Committing to action to transform vaccination in pharmacy From regional to global: Common priorities for action to transform vaccination Necesidades e impulsores regionales de la transformación de la vacunación: Américas Regional needs and drivers for transforming vaccination: Africa Regional needs and drivers for transforming vaccination: Western Pacific Regional needs and drivers for transforming vaccination: Eastern Mediterranean Regional needs and drivers for transforming vaccination: South East Asia Regional needs and drivers for transforming vaccination: Europe Setting transformative goals for vaccination globally Self-care: managing mild COVID-19 symptoms, dispelling the myths COVID-19 Guidance on Evaluation of Diagnostic Testing & Methods Pharmacist vaccinators and patient safety: FIP DG 19 Patient Safety The Role of Pharmacist Vaccinators in improving access to and equity in healthcare outcomes: FIP DG 10 Equity & equality and FIP DG18 Access to Medicines & Services Covid-19: toma de decisiones en ausencia de evidencia científica. Farmacovigilancia y tecnovigilancia como herramientas para evaluación de riesgo Pharmacist vaccinators and antimicrobial stewardship: FIP DG 17 Antimicrobial Stewardship Pharmacist vaccinators and communicable disease management: FIP DG 16 Communicable Diseases Removing policy barriers to pharmacist vaccinations: FIP DG 13 Policy Development Empowering pharmacists to deliver vaccination at the health-system level: FIP DG 7 Advancing Integrated Services COVID-19 Complex Case Presentations Vaccination from specialist practice to every day practice: FIP DG 4 Advanced & Specialist Development Reviewing the FIP Transforming Vaccination Programme: Enabling and supporting our profession Enabling our workforce: Supporting ongoing competence Transforming our workforce: Evolving the pharmacist's qualification Medicines use and quality Avances en el desarrollo de vacunas contra COVID-19 e importancia de la vacunación en tiempos de pandemia. Medicines shortages mitigation and waste optimization Addressing barriers to uptake: Adherence, misinformation & anti-Science Enabling practice: Empowering pharmacists & removing barriers Introducing the FIP 'Transforming Vaccination Globally & Regionally' series Programme… needs, action and outcomes Launch of the FIP AMR Commission Transforming Global Pharmacy: Launch of the FIP Development Goals FIP AMR African Regional Workshop FIP AMR European Regional Workshop FIP AMR Americas Regional Workshop FIP AMR South East Asian Regional Workshop FIP AMR Eastern Mediterranean Regional Workshop FIP AMR Western Pacific Regional Workshop Driving AMR action in a new decade Pharmacy Practice Research priorities during the COVID-19 pandemic Efectos del COVID-19 en la salud de los profesionales sanitarios y estrategias futuras de prevención Evidence-based practice during the COVID-19 pandemic The Rise of Substandard & Falsified Medical Products during the COVID-19 (Part2) Medicine supply disruptions and shortages during the pandemic Key considerations for developing COVID-19 treatments: learning from the past and planning for the future #AfricaTogether Pharmacy against COVID-19 COVID-19 for hospital pharmacists and health-systems: The medication use process Good pharmacy practice during the COVID-19 pandemic The rise of substandard & falsified medical products during the COVID-19 pandemic World pharmacists’ COVID-19 online meeting Targeted medication safety best practices for hospitals What you need to know about the FIP Pharmaceutical Workforce Development Goals Co-administration of flu and COVID vaccines: Improving convenience and vaccination coverage Therapeutic advances against COVID-19 Combatting Malaria: New horizon of vaccines and drug discovery by young pharmaceutical scientists

Non-communicable diseases (NCDs): Work in progress for the FIP NCDs website. Responsible use of medicines: FIP publications and digital events on responsible use of medicines are providing an overview of FIP’s programme areas. Patient safety: https://www.fip.org/patient-safety Prevention: Work in progress for the FIP Prevention website. COVID-19: https://www.fip.org/coronavirus Self-care: Work in progress for the FIP FIP Prevention website.